RE:RE:RE:RE:RE:For anybody interested in the CYDY storyYou know that better than me but CYDY is working on a particular segment of the US market, penny stocks not listed on a major stock exchange. They also have a large following on US boards discussing such dubious stocks. I don't know if they pay people to push them on such discussion boards. From the outside, to me, it looks like there is a specialized market in the US for gullible investors and some know this is just a big fraud, but they also know that with proper pumping there is money to be made because there is enough people willing to believe all the lies for a while.
Thera is a serious company and they will never engage in this crazy market. We saw something similar withThera after the approval of Trogarzo. Many jumped in for a short ride up, then jumped out more and more when it became clearer that this drug would not meet to sales that were promised. In this case, at least there was a real drug with a real approval. In the case of CYDY, all was pipe dreams and it reached a much higher market cap than Thera at the height of the Trogarzo approval rise.
SPCEO1 wrote: If the world were normal, this process would already be well advanced. Instead, somehow CYDY has been able to keep all of its spinning plates spinning on the end of those long wobbily sticks and finding people to buy into their utter nonsense while TH has made many notable scientific and regulatory advances, yet no one believes in them. It is one of the most bizarre things I have ever seen. When the Trogarzo deal was first signed we quickly went searching for potential competitors and found CYDY. With regard to MDR, both companies were at a somewhat similar place in the development process but Trogarzo clearly had the backing of the FDA. Now, many years later, Trogarzo has been on the market for nearly three years, TH has added a phase III ready NASH program and a potentially very exciting cancer program as well. During this same time, CYDY accomplished exactly zero. Yet there is CYDY's market cap at $446 million versus TH's at $278 million.
If anyone can make any sense of this, please help!
jfm1330 wrote: It would be fitting to see CYDY back to where it belongs because it is an empty fraudulent shell, and to finally see Thera rise with clear good clinical results out of solid science and steady development work. I really hope it will happen, first for my personal interest, but also as a good lesson about investment. Like a Hollywood movie where the good one wins at the end.